CID 6441894
Oraposide
Structural Information
- Molecular Formula
- C29H34O15
- SMILES
- C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]3[C@H](OCC(O3)C4=CC(=C(C=C4)O)O)O[C@@H]([C@H]2OC(=O)/C=C/C5=CC(=C(C=C5)O)O)CO)O)O)O
- InChI
- InChI=1S/C29H34O15/c1-12-22(36)23(37)24(38)28(40-12)44-26-25(43-21(35)7-3-13-2-5-15(31)17(33)8-13)19(10-30)42-29-27(26)41-20(11-39-29)14-4-6-16(32)18(34)9-14/h2-9,12,19-20,22-34,36-38H,10-11H2,1H3/b7-3+/t12-,19+,20?,22-,23+,24+,25+,26-,27-,28-,29+/m0/s1
- InChIKey
- FPOYEEKZOOLVJA-DNBQVIFESA-N
- Compound name
- [(4aR,6R,7R,8S,8aS)-2-(3,4-dihydroxyphenyl)-6-(hydroxymethyl)-8-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-3,4a,6,7,8,8a-hexahydro-2H-pyrano[2,3-b][1,4]dioxin-7-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 623.19704 | 240.6 |
[M+Na]+ | 645.17898 | 240.8 |
[M+NH4]+ | 640.22358 | 240.2 |
[M+K]+ | 661.15292 | 246.7 |
[M-H]- | 621.18248 | 233.7 |
[M+Na-2H]- | 643.16443 | 260.0 |
[M]+ | 622.18921 | 238.4 |
[M]- | 622.19031 | 238.4 |